Related Experiment Videos
Renal hypophosphatemic osteomalacia unmasked by hyperthyroidism
The American Journal of the Medical Sciences
|October 1, 1986
Summary
Hyperthyroidism can unmask renal hypophosphatemic osteomalacia (RHO), a rare bone disease. Prompt diagnosis and treatment with phosphate and calcitriol are crucial for reversing RHO and preventing fractures.
Area of Science:
- Endocrinology
- Nephrology
- Bone Metabolism
Background:
- Renal hypophosphatemic osteomalacia (RHO) is a rare metabolic bone disorder.
- Hyperthyroidism can significantly impact bone and mineral metabolism.
Observation:
- A 64-year-old patient presented with recurrent pathologic leg fractures.
- Initial evaluation revealed hyperthyroidism, which was treated, but fractures persisted.
- Histological and biochemical analyses confirmed osteomalacia consistent with RHO.
Findings:
- The patient exhibited elevated serum alkaline phosphatase and decreased serum phosphate and tubular phosphate resorption.
- Serum calcium, parathyroid hormone, and vitamin D levels were within normal ranges.
- Other causes of osteomalacia were excluded, establishing the diagnosis of RHO.
Implications:
- This case highlights that hyperthyroidism can unmask underlying metabolic bone diseases like RHO.
- Physicians should consider metabolic bone disorders in adults with unexplained fractures, especially when comorbidities like hyperthyroidism are present.
- Early recognition and management of RHO are essential to prevent skeletal complications.